Literature DB >> 10147031

The economics of an intensive education programme for asthmatic patients: a prospective controlled trial.

B Søondergaard1, F Davidsen, B Kirkeby, M Rasmussen, H Hey.   

Abstract

The costs and benefits of a planned patient education programme for patients with asthma were evaluated in a controlled trial. The patient education group received a planned patient education programme, performed by a physician, a pharmacist and a nurse over a 6-month period. Changes in the use of resources, productive output and in health status were measured for the patient education group and the control group. The total cost for planning, implementation and evaluation of the programme was 14074 British pounds sterling. The patient education group increased its contacts to general practitioners and the extra costs totalled 252 British pounds sterling. The increased costs of drugs used by the patient education group in the 6-month period was 2313 British pounds sterling compared with costs in the control group. The number of days lost through sickness decreased in the patient education group, corresponding to a 4528 British pounds sterling saving of otherwise lost earnings. The quality of life increased in the patient education group by 3.2 points on the Psychosomatic Discomfort Scale (2.9%). Health status increased by 38.9%. The study shows that the patient education programme has a positive clinical effect on the patient's quality of life and health status. The economic consequences of the implementation programme depend on the specific setup of the local healthcare system, where the programme is applied.

Entities:  

Mesh:

Year:  1992        PMID: 10147031     DOI: 10.2165/00019053-199201030-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  19 in total

1.  Patient compliance with medication regimens.

Authors:  D L Smith
Journal:  Drug Intell Clin Pharm       Date:  1976-07

2.  Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department.

Authors:  F Davidsen; T Haghfelt; L F Gram; K Brøsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Economics of coronary artery bypass grafting.

Authors:  A Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

4.  Drug-related problems causing admission to a medical clinic.

Authors:  U Bergman; B E Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Developing a patient education program in the community pharmacy.

Authors:  K W Witte; K F Bober
Journal:  Am Pharm       Date:  1982-10

6.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

7.  Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease.

Authors:  R M Kaplan; C J Atkins; R Timms
Journal:  J Chronic Dis       Date:  1984

8.  A randomized trial of A.C.T. (asthma care training) for kids.

Authors:  C E Lewis; G Rachelefsky; M A Lewis; A de la Sota; M Kaplan
Journal:  Pediatrics       Date:  1984-10       Impact factor: 7.124

9.  Education for self-treatment by adult asthmatics.

Authors:  L A Maiman; L W Green; G Gibson; E J MacKenzie
Journal:  JAMA       Date:  1979-05-04       Impact factor: 56.272

10.  Strategies for enhancing patient compliance.

Authors:  M H Becker; L A Maiman
Journal:  J Community Health       Date:  1980
View more
  4 in total

Review 1.  The limited incorporation of economic analyses in clinical practice guidelines.

Authors:  Joel F Wallace; Scott R Weingarten; Chiun-Fang Chiou; James M Henning; Andriana A Hohlbauch; Margaret S Richards; Nicole S Herzog; Lior S Lewensztain; Joshua J Ofman
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

2.  Parental education and guided self-management of asthma and wheezing in the pre-school child: a randomised controlled trial.

Authors:  C A Stevens; L J Wesseldine; J M Couriel; A J Dyer; L M Osman; M Silverman
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

Review 3.  Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthma.

Authors:  D H Peters; D Faulds
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

4.  Pharmacoeconomic assessment of clinical pharmacist interventions for patients with moderate to severe asthma in outpatient clinics : experience in taiwan.

Authors:  Agnes L F Chan; Hue-Yu Wang
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.